Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance
Zambrano-Villacres R, Campuzano-Donoso M, Reytor-González C, et al.
Nutrients, 2026;18(11)
Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans
Johnson AA, Sinclair DA
Frontiers in genetics, 2026;17:1836446
Activation of GLP-1R ameliorates alcohol withdrawal induced anxiety-like behavior by regulating neuronal mitochondrial quality control
Wang Z, Zhao W, Chen X, et al.
Frontiers in pharmacology, 2026;17:1820128
Formulation Engineering of Oral Semaglutide Tablets: Unleashing Gastric Intestinal Permeation with Sodium Caprate
Kim DH, Hwang SK, Yoon JH, et al.
Pharmaceutics, 2026;18(6)
Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH
Dinkov B
Biomedicines, 2026;14(6)
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
Yıldırım AK, Demirtaş H, Özer A, et al.
Scientific reports, 2026
LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma
Zhang Y, Qian S, Yang Q, et al.
Cell death & disease, 2026
Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide
Olson TE, Lloyd TS, Hamad CD, et al.
JOR spine, 2026;9(2):e70196
Inter-organ communication shapes human metabolic tissue states and resolves anti-diabetic drug response modes in a six-tissue microphysiological system
McGilvrey M, Chew S, Siddiqui MF, et al.
bioRxiv : the preprint server for biology, 2026
Lean Mass and Musculoskeletal Preservation in GLP-1-Based Obesity Treatment: Nutrition, Exercise, Supplementation, and Monitoring Strategies
Šantić R, Martinović L, Pavlović N, et al.
Metabolites, 2026;16(6)
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs
Mazzola J, Rosenfeld M, Tucker M, et al.
Research square, 2026
Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study
Sumbul HE, Isik B, Mustan AG, et al.
Journal of clinical medicine, 2026;15(11)
Redox-Driven Blood-Nerve Barrier Dysfunction in Diabetic Peripheral Neuropathy: Mechanisms and Therapeutic Opportunities
Huang WH, Wong CS
Antioxidants (Basel, Switzerland), 2026;15(6)
Benefits of Incretin Therapy on Ovarian Function: A Scientific Literature Review
La Vignera S, Condorelli RA
International journal of molecular sciences, 2026;27(11)
Impact of GLP-1 Receptor Agonists on Chronic Low Back Pain in Patients with Obesity: A Prospective Pilot Cohort Study
Benedict B, White-Gilliam D, Pradhan A, et al.
medRxiv : the preprint server for health sciences, 2026
Type B insulin resistance with glycemic extremes: a case report and literature review
Ngo EMT, Rowe JM, Chillon TS, et al.
Frontiers in endocrinology, 2026;17:1852784
GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review
Myśliwczyk D, Gofron KK, Wasilewski A, et al.
Nutrients, 2026;18(11)
Retrospective Comparative Study of Oral Versus Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus
Toffoli B, Michieletto M, Bernardi S, et al.
International journal of molecular sciences, 2026;27(11)
Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses
Ye Y, Yang X, Liu Y, et al.
Biomolecules, 2026;16(6)
Association of Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Pan SY, Weng CH, Sheen YJ, et al.
Ophthalmology science, 2026;6(7):101245